---
document_datetime: 2023-09-21 21:05:53
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/proquad-epar-all-authorised-presentations_en.pdf
document_name: proquad-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.9218732
conversion_datetime: 2025-12-20 16:08:45.098853
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form                             | Route of administration           | Immediate Packaging                                                      | Content (concentration)   | Pack size                                        |
|------------------|-------------------|------------|-------------------------------------------------|-----------------------------------|--------------------------------------------------------------------------|---------------------------|--------------------------------------------------|
| EU/1/05/323/001  | ProQuad           | §          | Powder and solvent for suspension for injection | Subcutaneous or intramuscular use | powder: vial (Type I glass); solvent: vial (Type I glass)                | 0.5 ml                    | 1 vial + 1 vial                                  |
| EU/1/05/323/002  | ProQuad           | §          | Powder and solvent for suspension for injection | Subcutaneous or intramuscular use | powder: vial (Type I glass); solvent: vial (Type I glass)                | 0.5 ml                    | 10 vials + 10 vials                              |
| EU/1/05/323/005  | ProQuad           | §          | Powder and solvent for suspension for injection | Subcutaneous or intramuscular use | powder: vial (Type I glass); solvent: pre- filled syringe (Type glass)   | I 0.5 ml                  | 1 vial + 1 pre-filled syringe without needle     |
| EU/1/05/323/006  | ProQuad           | §          | Powder and solvent for suspension for injection | Subcutaneous or intramuscular use | powder: vial (Type I glass); solvent: pre- filled syringe (Type I glass) | 0.5 ml                    | 10 vials + 10 pre-filled syringes without needle |
| EU/1/05/323/007  | ProQuad           | §          | Powder and solvent for suspension for injection | Subcutaneous or intramuscular use | powder: vial (Type I glass); solvent: pre- filled syringe (Type I glass) | 0.5 ml                    | 20 vials + 20 pre-filled syringes without needle |
| EU/1/05/323/008  | ProQuad           | §          | Powder and solvent for suspension for injection | Subcutaneous or intramuscular use | powder: vial (Type I glass); solvent: pre- filled syringe (Type I glass) | 0.5 ml                    | 1 vial + 1 pre-filled syringe + 1 needle         |
| EU/1/05/323/009  | ProQuad           | §          | Powder and solvent for suspension for injection | Subcutaneous or intramuscular use | powder: vial (Type I glass); solvent: pre- filled syringe (Type I glass) | 0.5 ml                    | 10 vials + 10 pre-filled syringes + 10 needles   |
| EU/1/05/323/010  | ProQuad           | §          | Powder and solvent for suspension for injection | Subcutaneous or intramuscular use | powder: vial (Type I glass); solvent: pre- filled syringe (Type I glass) | 0.5 ml                    | 1 vial + 1 pre-filled syringe + 2 needles        |
| EU/1/05/323/011  | ProQuad           | §          | Powder and solvent for suspension for injection | Subcutaneous or intramuscular use | powder: vial (Type I glass); solvent: pre- filled syringe (Type I glass) | 0.5 ml                    | 10 vials + 10 pre-filled syringes + 20 needles   |
| EU/1/05/323/012  | ProQuad           | §          | Powder and solvent                              | Subcutaneous or                   | powder: vial (Type I                                                     | 0.5 ml                    | 20 vials + 20 pre-filled                         |

<div style=\"page-break-after: always\"></div>

|                 |         |    | for suspension for injection                    | intramuscular use                 | glass); solvent: pre- filled syringe (Type I glass)                             | syringes + 20 needles                          |
|-----------------|---------|----|-------------------------------------------------|-----------------------------------|---------------------------------------------------------------------------------|------------------------------------------------|
| EU/1/05/323/013 | ProQuad | §  | Powder and solvent for suspension for injection | Subcutaneous or intramuscular use | powder: vial (Type I glass); solvent: pre- filled syringe (Type I glass) 0.5 ml | 20 vials + 20 pre-filled syringes + 40 needles |

§

Measles virus 1

Enders' Edmonston strain (live, attenuated) ........ not less than 3.00 log 10 TCID

Mumps virus 1

Jeryl Lynn™ (Level B) strain (live, attenuated) ..... not less than 4.30 log 10 TCID

Rubella virus 2

Wistar RA 27/3 strain (live, attenuated) .............. not less than 3.00 log 10 TCID

50

50

50

Varicella virus 3 Oka/Merck strain (live, attenuated) ................... not less than 3.99 log 10 PFU**

* 50% tissue culture infectious dose
- ** plaque-forming units
- ( 1 ) Produced in chick embryo cells.
- ( 2 ) Produced in human diploid lung (WI-38) fibroblasts.
- ( 3 ) Produced in human diploid (MRC-5) cells.

*

*

*